The Valley Desk

Clinical trial reportThe Lancet. Child & adolescent healthPublished

Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, GSK, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Lancet. Child & adolescent health
Published
Subject terms
Humans; HIV-1; HIV Infections; Pyridones; Anti-HIV Agents; Drug Therapy, Combination; Viral Load; Adolescent; Child; South Africa; United States; Female
PubMed ID
42838065
Added to directory
Source checked

Report a correction or request removal